

The Chairman of Inmarsat made 1.4m pounds this week by selling around a fifth of his stake in the satellite operator, the firm announced on Thursday. ...


The FTSE Small Cap index firms 0.1 percent, mirroring strength from the blue chips, while junior-listed AIM shares drop 0.1 percent. China-based healt...


Barclays: Morgan Stanley lowers target price from 438p to 424p and reiterates an overweight rating. Bellzone Mining: Investec reduces target price fr...


Nestlé Health Science SA, a fully-owned subsidiary of Nestlé SA, and Hutchison China MediTech have announced that all regulatory approvals required fo...


Aberdeen Asset Management: Morgan Stanley raises target price from 365p to 375p; keeping an overweight rating. ASOS: Societe Generale raises target p...


Pharmaceutical company Hutchison China MediTech (Chi-MEd) has announced that through its majority-owned research and development company it has initia...


Michael Howell, an Independent Non-Executive Director at Hutchison China Meditech, a research and development company majority-owned by Chi-Med, purch...


Hutchison China MediTech (Chi-MEd) saw profits jump in the first half and said it was well-positioned to take advantage of the enormous Chinese market...